Kanzhun Ltd: Form 20-F for the period ended Dec 31, 2025
Filed with the SEC on Apr 29, 2026 and accepted by EDGAR at Apr 29, 2026, 08:43 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2025-01-01 to 2025-12-31 | $1.18bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2025-01-01 to 2025-12-31 | $176.6m | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 12 months2025-01-01 to 2025-12-31 | $236.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2025-01-01 to 2025-12-31 | $352.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2025-01-01 to 2025-12-31 | $72.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2025-01-01 to 2025-12-31 | $391.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2025-01-01 to 2025-12-31 | $0.42 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2025-01-01 to 2025-12-31 | $0.43 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2025-01-01 to 2025-12-31 | 926,992,531 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2025-01-01 to 2025-12-31 | $651.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2025-01-01 to 2025-12-31 | $17.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2025-01-01 to 2025-12-31 | $79.1m | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months2025-01-01 to 2025-12-31 | $20.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-12-31 | $587.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-12-31 | $2.91bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $3.51bn | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $625.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $641.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-12-31 | $2.86bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-26-050959. Last ingested by Listed: Nov 5, 2026, 16:23 ET. Listed shows no prices and gives no investment advice.